TITLE

Current Concepts in the Management of Tuberculosis

AUTHOR(S)
Sia, Irene G.; Wieland, Mark L.
PUB. DATE
April 2011
SOURCE
Mayo Clinic Proceedings;Apr2011, Vol. 86 Issue 4, p348
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Tuberculosis (TB) poses a serious threat to public health throughout the world but disproportionately afflicts low-income nations. Persons in close contact with a patient with active pulmonary TB and those from endemic regions of the world are at highest risk of primary infection, whereas patients with compromised immune systems are at highest risk of reactivation of latent TB infection (LTBI). Tuberculosis can affect any organ system. Clinical manifestations vary accordingly but often Include fever, night sweats, and weight loss. Positive results on either a tuberculin skin test or an interferon-γ release assay in the absence of active TB establish a diagnosis of LTBI. A combination of epidemiological, clinical, radiographic, microbiological, and histopathologic features is used to establish the diagnosis of active TB. Patients with suspected active pulmonary TB should submit 3 sputum specimens for acid-fast bacilli smears and culture, with nucleic acid amplification testing performed on at least 1 specimen. For patients with LTBI, treatment with isoniazid for 9 months is preferred. Patients with active TB should be treated with multiple agents to achieve bacterial clearance, to reduce the risk of transmission, and to prevent the emergence of drug resistance. Directly observed therapy is recommended for the treatment of active TB. Health care professionals should collaborate, when possible, with local and state public health departments to care for patients with TB. Patients with drug-resistant TB or coinfection with human immunodeficiency virus should be treated in collaboration with TB specialists. Public health measures to prevent the spread of TB include appropriate respiratory isolation of patients with active pulmonary TB, contact investigation, and reduction of the LTBI burden.
ACCESSION #
59803648

 

Related Articles

  • Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa. Shenoi, Sheela V.; Brooks, Ralph P.; Barbour, Russell; Altice, Frederick L.; Zelterman, Daniel; Moll, Anthony P.; Master, Iqbal; Merwe, Theo L. van der; Friedland, Gerald H. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Drug-resistant tuberculosis (TB) is a major threat to global public health. Patients with extensively drugresistant TB (XDR-TB), particularly those with HIV-coinfection, experience high and accelerated mortality with limited available interventions. To determine modifiable factors...

  • Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa. Shenoi, Sheela V.; Brooks, Ralph P.; Barbour, Russell; Altice, Frederick L.; Zelterman, Daniel; Moll, Anthony P.; Master, Iqbal; Merwe, Theo L. van der; Friedland, Gerald H. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Drug-resistant tuberculosis (TB) is a major threat to global public health. Patients with extensively drugresistant TB (XDR-TB), particularly those with HIV-coinfection, experience high and accelerated mortality with limited available interventions. To determine modifiable factors...

  • COMMENT ON NAME-BASED REPORTING. Catania, Joseph A.; Osmond, Dennis // American Journal of Public Health;Oct2008, Vol. 98 Issue 10, p1735 

    The article presents the authors' comment on researcher J. Tesoriero and colleagues paper "The Effect of Name-Based Reporting and Partner Notification on HIV Testing in New York State." The authors note several limitations to the data bases used by Tesoriero et al. to address the impact of...

  • Outbreak of Multidrug-Resistant Salmonella Typhimurium Associated With Rodents Purchased at Retail Pet Stores—United States, December 2003–October 2004. Smith, K.; Boxrud, D.; Leano, F.; Snider, C.; Braden, C.; Lockett, J.; Montgomery, S.; Swanson, S.; O'Reilly, C. // JAMA: Journal of the American Medical Association;6/22/2005, Vol. 293 Issue 24, p2994 

    Reports research on an outbreak of multidrug-resistant Salmonella enterica serotype Typhimurium in the United States during December 2003 to October 2004. Association of the disease with hamsters received from an Iowa pet distributor; Details of the South Carolina and Minnesota cases; States...

  • Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors. Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Bhaijee, Feriyl; Maartens, Gary; McIlleron, Helen; De Azevedo, Virginia; Cox, Helen; McDermid, Cheryl; Sokhela, Simiso; Patel, Janisha; Meintjes, Graeme // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p83 

    Background: HIV-1 and Mycobacterium tuberculosis cause substantial morbidity and mortality. Despite the availability of antiretroviral and antituberculosis treatment in Africa, clinical deterioration during antituberculosis treatment remains a frequent reason for hospital admission. We therefore...

  • Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries. Schluger, Neil; Karunakara, Unni; Lienhardt, Christian; Nyirenda, Thomas; Chaisson, Richard // PLoS Medicine;Nov2007, Vol. 4 Issue 11, pe302 

    The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.

  • Treatment of tuberculosis and optimal dosing schedules. Kwok Chiu Chang; Chi Chiu Leung; Grosset, Jacques; Yew, Wing Wai // Thorax;Nov2011, Vol. 66 Issue 11, p997 

    Intermittent tuberculosis treatment regimens have been developed to facilitate treatment supervision. Their efficacy has been substantiated by clinical trials and tuberculosis control programmes, notwithstanding the lack of head-to-head comparison between daily and intermittent regimens....

  • Modelling imperfect adherence to HIV induction therapy. Miron, Rachelle E.; Smith, Robert J. // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p6 

    Background: Induction-maintenance therapy is a treatment regime where patients are prescribed an intense course of treatment for a short period of time (the induction phase), followed by a simplified long-term regimen (maintenance). Since induction therapy has a significantly higher chance of...

  • Improving systems to monitor transmitted HIV drug resistance. Bertagnolio, Silvia // BMJ: British Medical Journal;10/6/2012, Vol. 345 Issue 7877, p9 

    The author discusses HIV drug resistance and refers to a study which suggests that treatment regimens remain effective for most people in Great Britain. However, variability exists in levels of transmitted resistance across high income countries. The author discusses factors that could affect...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics